Curis Inc (CRIS) stock
CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.45−0.13 (-22.18%)
Close on Nov 13, 2026Market cap $930.08KP/E –Yield –
Curis profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Curis's profit margin for the twelve months ending Jun 30, 2026 was -490.3%. For fiscal 2025 it was -80.3%, against -397.8% the year before. The highest annual figure on record is -27.7% in fiscal 2010.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -80.3% | +317.5 |
| FY2024 | Dec 31, 2024 | -397.8% | +75.3 |
| FY2023 | Dec 31, 2023 | -473.0% | +84.6 |
| FY2022 | Dec 31, 2022 | -557.7% | −131.0 |
| FY2021 | Dec 31, 2021 | -426.7% | −150.6 |
| FY2020 | Dec 31, 2020 | -276.0% | +45.3 |
| FY2019 | Dec 31, 2019 | -321.3% | −8.9 |
| FY2018 | Dec 31, 2018 | -312.4% | +226.3 |
| FY2017 | Dec 31, 2017 | -538.7% | +263.9 |
| FY2016 | Dec 31, 2016 | -802.6% | −53.9 |
| FY2015 | Dec 31, 2015 | -748.7% | −558.4 |
| FY2014 | Dec 31, 2014 | -190.3% | −108.1 |
| FY2013 | Dec 31, 2013 | -82.1% | +14.6 |
| FY2012 | Dec 31, 2012 | -96.7% | −29.9 |
| FY2011 | Dec 31, 2011 | -66.8% | −39.1 |
| FY2010 | Dec 31, 2010 | -27.7% | +86.6 |
| FY2009 | Dec 31, 2009 | -114.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | 1700.9% | +1988.4 |
| Q3 FY2025 | Sep 30, 2025 | -243.4% | +101.0 |
| Q2 FY2025 | Jun 30, 2025 | -312.6% | +151.0 |
| Q1 FY2025 | Mar 31, 2025 | -446.1% | +123.3 |
| Q4 FY2024 | Dec 31, 2024 | -287.5% | +146.9 |
| Q3 FY2024 | Sep 30, 2024 | -344.3% | +85.6 |
| Q2 FY2024 | Jun 30, 2024 | -463.6% | +80.8 |
| Q1 FY2024 | Mar 31, 2024 | -569.3% | −66.1 |
| Q4 FY2023 | Dec 31, 2023 | -434.4% | −42.0 |
| Q3 FY2023 | Sep 30, 2023 | -430.0% | +40.6 |
| Q2 FY2023 | Jun 30, 2023 | -544.4% | +121.7 |
| Q1 FY2023 | Mar 31, 2023 | -503.2% | +279.9 |
| Q4 FY2022 | Dec 31, 2022 | -392.4% | +42.0 |
| Q3 FY2022 | Sep 30, 2022 | -470.6% | −106.9 |
| Q2 FY2022 | Jun 30, 2022 | -666.1% | −192.0 |
| Q1 FY2022 | Mar 31, 2022 | -783.1% | −329.6 |
| Q4 FY2021 | Dec 31, 2021 | -434.4% | −185.9 |
| Q3 FY2021 | Sep 30, 2021 | -363.6% | −145.8 |
| Q2 FY2021 | Jun 30, 2021 | -474.1% | −189.9 |
| Q1 FY2021 | Mar 31, 2021 | -453.5% | −95.1 |
| Q4 FY2020 | Dec 31, 2020 | -248.6% | +13.3 |
| Q3 FY2020 | Sep 30, 2020 | -217.9% | +7.5 |
| Q2 FY2020 | Jun 30, 2020 | -284.2% | +60.2 |
| Q1 FY2020 | Mar 31, 2020 | -358.4% | +201.0 |
| Q4 FY2019 | Dec 31, 2019 | -261.9% | −46.3 |
| Q3 FY2019 | Sep 30, 2019 | -225.4% | +28.4 |
| Q2 FY2019 | Jun 30, 2019 | -344.5% | +23.0 |
| Q1 FY2019 | Mar 31, 2019 | -559.4% | −123.9 |
| Q4 FY2018 | Dec 31, 2018 | -215.6% | +30.5 |
| Q3 FY2018 | Sep 30, 2018 | -253.7% | +378.7 |
| Q2 FY2018 | Jun 30, 2018 | -367.4% | +316.2 |
| Q1 FY2018 | Mar 31, 2018 | -435.5% | +303.3 |
| Q4 FY2017 | Dec 31, 2017 | -246.1% | +233.8 |
| Q3 FY2017 | Sep 30, 2017 | -632.4% | – |
| Q2 FY2017 | Jun 30, 2017 | -683.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -738.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -479.9% | – |
See a number that looks wrong?